Meta-analysis comparing doublet and single cytotoxic agent therapy as first-line treatment in elderly patients with advanced nonsmall-cell lung cancer

Conclusions
Doublet therapy was associated with significantly increased OS, 1-year SR and ORR compared with single agent therapy. Race may be considered when choosing doublet versus single-agent therapy as first-line treatment of NSCLC in elderly patients.

Source: Journal of International Medical Research - December 9, 2015 Category: Research Authors: Wang, S., Wang, Q., Tian, J., Zhou, Z., Jiao, L., Fu, Y., Chen, S., Zhang, J., Xu, L. Tags: Meta-Analysis Source Type: research